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a  b  s  t  r  a  c  t
Brucellosis  is a highly  contagious  zoonosis  caused  by bacteria  of  the  genus  Brucella  and  affecting  domestic
and  wild  mammals.  In this  paper,  the bacteriological  and  serological  evidence  of  brucellosis  in Sub-
Saharan  Africa  (SSA)  and  its epidemiological  characteristics  are  discussed.  The  tools  available  for  the
diagnosis  and  treatment  of  human  brucellosis  and  for the  diagnosis  and  control  of  animal  brucellosis  and
their  applicability  in  the  context  of SSA  are  presented  and  gaps  identified.  These  gaps  concern  mostly
the  need  for  simpler  and  more  affordable  antimicrobial  treatments  against  human  brucellosis,  the  devel-eywords:
rucellosis
ub-Sahara
frica
iagnosis
accination
opment  of a B. melitensis  vaccine  that  could  circumvent  the  drawbacks  of the currently  available  Rev  1
vaccine,  and  the  investigation  of  serological  diagnostic  tests  for camel  brucellosis  and  wildlife.  Strategies
for  the implementation  of  animal  vaccination  are  also  discussed.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ontrol
. Introduction
Brucellosis is the collective name given to a group of zoonoses
aused by gram-negative bacteria of the genus Brucella. The disease
as a worldwide distribution and affects economically important
omestic livestock as well as a wide range of wild mammals
Godfroid et al., 2011; Zheludkov and Tsirelson, 2010). Brucella
bortus, B. melitensis and B. suis are the species that have the high-
st impact on domestic livestock productivity and human health
Godfroid et al., 2011) and, although they preferentially infect cat-
le, small ruminants and swine, respectively, cross-infections may
e significant in mixed husbandry systems or at the livestock-
ildlife interface (Godfroid et al., 2013; Verger et al., 1989;Please cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
heludkov and Tsirelson, 2010). Eradicated from cattle and small
uminants in a handful of industrialized countries, brucellosis
emains endemic in most areas of the world (Moreno, 2014).
∗ Corresponding author. Fax: +34948425649.
E-mail address: imoriyon@unav.es (I. Moriyón).
ttp://dx.doi.org/10.1016/j.actatropica.2015.10.023
001-706X/© 2015 The Authors. Published by Elsevier B.V. This is an open access article 
/).Brucellosis is a “difficult disease” (Cunningham, 1977). In addi-
tion to the wide range of hosts (and subsequent multifaceted
epidemiology) and the socioeconomic implications, brucellosis is
not readily identified because of its variable picture at both indi-
vidual and population level. The main clinical signs in bovines
and small ruminants are abortions and infertility, but they are
neither disease-specific nor present in all infected individuals
(Cunningham, 1977). Since abortion usually occurs in the first preg-
nancy after infection and becomes less likely thereafter because
of sustained immunity, the introduction of infected animals into
immunologically naïve groups (or of unprotected replacements in
infected groups) results in multiple abortions in a short period
of time (“abortion storms”) (Cunningham, 1977). Whereas expo-
sure to the billions of bacteria released (Corner, 1983) can be
controlled to some extent by proper animal management, con-
genital transmission and the consequent existence of initiallyb-Saharan Africa: Current challenges for management, diagnosis
.2015.10.023
asymptomatic and seronegative animals that subsequently become
contagious pose a difficult challenge (Catlin and Sheehan, 1986;
Plommet, 1977; Ray et al., 1988). When the “acute” phase has
passed, individual prevalence stabilizes or even decreases because
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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f the development of herd immunity and a reduced exposure to
eavy bacterial challenges, and clinical signs become much less dis-
ernible. However, the disease becomes “chronic” in the herd, flock
r farm. This “acute”/“chronic” dynamic has been recognized for a
ong time (Cunningham, 1977) and, as expected, there are fluctu-
tions between these extreme situations caused by management
ractices such as intensification, sedentarization and the intro-
uction of unprotected exotic breeds (Akakpo, 1987; Akakpo and
ornarel, 1987; Alton, 1981; Roux, 1979). Accordingly, whereas the
verall individual prevalence and abortion rates in an endemic area
re often moderate, the proportion of infected herds, flocks or farms
sually remains high and is the true indicator of the potential of the
isease to flare up when conditions promoting transmission occur.
Human brucellosis is a debilitating disease that lacks pathog-
omonic symptoms (Ariza, 1999; Dalrymple-Champneys, 1960;
pink, 1956), which makes it difficult to distinguish from other
ebrile conditions, including malaria (Chabasse et al., 1983; El
nsary et al., 2001; Maichomo et al., 1998; Mangen et al., 2002;
ert et al., 2003; Muriuki et al., 1997; Mutanda, 1998). B. melitensis
s the cause of most of the reported cases of human brucellosis and
auses the most severe form of the disease, followed by B. suis and B.
bortus; much less frequent are infections by B. canis, a species that
s restricted to dogs (Ariza, 1999; Moreno, 2014; Spink, 1956). Since
here is no human vaccine and no significant human-to-human
ransmission, control of animal brucellosis, milk pasteurization and
ther food hygiene measures are the only options to reduce its
ccurrence in humans.
Despite underreporting and the scarcity of epidemiologically
alid data, the evidence obtained throughout the years shows
hat brucellosis is a widespread problem in Africa (Akakpo, 1987;
ucrotoy et al., 2014; Grace et al., 2012; Mangen et al., 2002;
cDermott et al., 2013; Thimm and Wundt, 1976) a continent
here several Sub Saharan countries are estimated to bear a high
urden of neglected zoonotic diseases (Grace et al., 2012).
The purpose of this article is twofold. First, we discuss the char-
cteristics of brucellosis in Sub Saharan Africa (SSA), that is, the
rucella species involved and epidemiological peculiarities, and thePlease cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
ariability of the clinical picture at herd and flock level, and the
easons for this diversity. To this end, we present bacteriological
vidence available since Brucella was first isolated in SSA, the expe-
ience gathered during the course of the European Union funded
ig. 1. Brucella potential hosts and livestock production systems in Africa.
ivestock density is expressed as the number of cattle (panel A) or small ruminants (B)
ifferentiate between zones of low and high livestock density (data derived from Gridded
roduction systems. Landless production systems are characterized by (i) less than 10% of
ry  matter that is farm produced, (iii) stocking rates of more than 10 livestock units per h
oultry. In mixed farming systems the non-livestock agriculture is responsible for a cons
hat  is irrigated. In the remaining non-mixed farming systems, livestock depends on gra
r  unsuitable for livestock is mainly categorized under “Other type” PRESS
ica xxx (2015) xxx–xxx
ICONZ project (http://www.iconzafrica.org), and data from solid
sero-epidemiological studies (Sections 2–5). An exhaustive review
of the serological evidence including all “grey literature” (Ducrotoy
et al., 2014) is out of the scope of this work, and we  have used the
literature available in PubMed since 2001 (see Supporting Mate-
rial) to update the evidence presented in the authoritative review
of McDermott and Arami (McDermott and Arimi 2002). The second
objective of the present work is to discuss the suitability of diagnos-
tic tools, treatments, vaccines and control strategies for the region
(Section 6), as well as critical aspects of brucellosis management
that have not been discussed previously in the context of SSA.
2. Brucella potential hosts and livestock production
systems in Africa
McDermott and Arimi (McDermott and Arimi, 2002) have
presented in detail the estimated distribution of livestock and pro-
ductions systems in SSA and here we will only summarize those
characteristics that are relevant for the discussions below (Fig. 1A
and B). But for the Nile delta and a few thin coastal strips, cat-
tle are mostly reared in the Sahel and Ethiopian highlands and in
Kenya, Tanzania, Uganda and other Eastern African countries of
the Great Lakes area and in Southern African countries, namely
Bostwana, Madagascar, South Africa, South West of Angola, Zambia
and Zimbabwe. Small ruminants are found in higher densities than
cattle and, although overlapping largely with the latter, penetrate
more deeply into semi-arid areas bordering the South and North
of Sahara and the horn of Africa. Livestock production systems are
shown in Fig. 1C grouped into five broad categories. In SSA, grazing
is the predominant production system but most cattle are dis-
tributed on mixed rain-fed systems. There are few (mixed) irrigated
areas that can support high stocking densities. The broad picture
is characterized by a scarcity of intensive livestock production sys-
tems and a dominance of extensive pastoralist or agro-pastoralist
systems where cattle and small ruminants are co-reared. Camelsb-Saharan Africa: Current challenges for management, diagnosis
.2015.10.023
in the northern and southern borders of Sahara and Ethiopia add
another dimension to these mixed breeding systems. In addition,
transhumance is practiced according to seasonal variations and
grazing availability in many areas.
 per square kilometer according to categories of different sizes in order to clearly
 Livestock of the World; http://livestock.geo-wiki.org). Panel C shows the livestock
 the income that comes from non-livestock agriculture, (ii) less than 10% of the feed
a of agriculture land and (iv) a higher ruminant enterprise value than that of pig or
iderable part of the income. A distinction is made between rain-fed crops and land
zing activities whether extensively mobile as pastoralists or not. Land inaccessible
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. Brucellosis in domestic animals in SSA
As the clinical signs of this disease are not specific, bru-
ellosis cannot be diagnosed clinically. Hygromas seem a good
ndirect indicator of brucellosis in African herds (Akakpo, 1987;
erney and Chantal, 1976; McDermott and Arimi, 2002) probably
ecause infected animals are kept long enough for this arthropa-
hy to develop. Although in African herds hygromas correlate more
losely than abortions with a positive brucellosis serology (Akakpo
nd Bornarel, 1987) and possibly represent one of samples of choice
or bacteriological studies (Sanogo et al., 2013), they are not pathog-
omonic and evidence has to be based on laboratory tests. Of these,
nly serological tests and bacteriological isolation are presently
alid because, despite their high analytical sensitivity under lab-
ratory conditions, the diagnostic sensitivity and specificity of PCR,
T-PCR and other DNA detection tests is undetermined (Yu and
ielsen, 2010).
.1. Brucella species
It is a well-established fact that the dominance and overlap-
ing nature of the C epitope of smooth brucellae (Alonso-Urmeneta
t al., 1998) makes it impossible to ascertain the infecting Brucella
pecies using serological tests, irrespective of the antigen (meliten-
is or abortus) or host species tested (Ariza, 1999; OIE, 2013a,b;
pink, 1956). Thus, bacteriological isolation is strictly necessary to
etermine the infecting Brucella species and to understand the epi-
emiology when different host species are managed together or
hare grazing grounds and water sources. However, identification
nd typing of Brucella species by conventional procedures is diffi-
ult and molecular methods are preferred for typing strains once
hese are isolated (OIE, 2013a). This is exemplified by the case of
he B. abortus biovar 3a strains of Nigeria (Bertu et al., 2015), orig-
nally reported as biovar 1 and thought to be an exception in the
rea [(Sanogo et al., 2013); see also below]. Moreover, these meth-
ds can provide insights into the origin of the strains that are not
vident from the results of classical phenotyping.
Despite the inconsistencies of reports, the presence of B. abortus
nd B. melitensis in African countries of the Mediterranean coast
s well known, and both classical biotyping and molecular studies
how that they are closely related to other strains in the Mediter-
anean basin (Lounes et al., 2014; Verger and Grayon, 1984). On
he other hand, the number of B. melitensis isolates from SSA is
ery limited (Table 1). Moreover, their identification as a classical
melitensis” spp. is not always clear. This is the case of the strains
solated from goats in Nigeria, since their biochemical character-
stics are atypical (Falade, 1981a) or their reported rough state
recludes clear assignment (Bale et al., 2003). Most isolates have
een obtained in Kenya (Table 1). Biovars 1 and 3 were reported in
heep and goats over 40 years ago, in one instance in an outbreak
ssociated with male goats imported from Israel and, interestingly,
 more recent isolate of B. melitensis from cattle that is closely
elated to Israel strains has been reported. These data could suggest
 Mediterranean origin of at least some the B. melitensis strains and
heir subsequent transmission of B. melitensis to cattle, as observed
n countries where cattle and small ruminants are kept together
Benkirane, 2006; Refai, 2002). Some biovar 1 strains were also iso-
ated from goats in Natal and Zimbabwe (Table 1). In humans, B.
elitensis was  isolated with frequency higher than B. abortus in
enya (Table 1), which conforms to the greater virulence of the
ormer species in humans, and in a case imported from SomaliaPlease cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
Table 1).
Brucella abortus encompasses the largest number of isolates,
resumably because cattle have been sampled more often than
mall ruminants. For West Africa, almost 90% of the isolates to PRESS
ica xxx (2015) xxx–xxx 3
date were reported over 30 years ago (Table 1). Remarkably, this
early work found only B. abortus biovar 3 in autochthonous cattle
in Senegal, Togo, Rwanda, Guinea Bissau and Niger, and identi-
fied significant differences between these isolates and biovar 3 of
European strains in oxidase and metabolic oxidative tests (Akakpo,
1987; Verger and Grayon, 1984). Consistent with this, the recent
molecular analyses (Table 1) show that strains isolated thus far in
SSA represent a genotype (B. abortus biovar 3a; Table 1) different
from that (B. abortus biovar 3b) isolated in Europe and Latin Amer-
ica (Bertu et al., 2015). Very recently, a B. abortus strain isolated in
Tanzania did not clearly group with 3a, and 11 B. abortus strains
isolated in Uganda that were found to be monomorphic at molec-
ular analysis may  belong to B. abortus biovar 7 (Table 1). Biovar
7, although suspended from Brucella nomenclature in 1988, has
been reintroduced again upon re-examination by molecular meth-
ods (Garin-Bastuji et al., 2014), and the original reference strain
was of African origin (Meyer and Morgan, 1973). It is notewor-
thy that B. abortus has been isolated several times from milk and
abortion products of sheep in Nigeria and also from a goat, and
the isolates that have been typed belong to the biovar 3a found
in cattle (Table 1). Similarly, the B. abortus strains isolated from
horses in Nigeria (Table 1) were of the same genotype found in cat-
tle. Finally, although little is known about the zoonotic potential of
biovar 3a (not all Brucella biovars are highly virulent for humans),
the B. abortus biovar 3 Tulya reference strain which we know now
belongs to biovar 3a (Ocampo-Sosa et al., 2005) was originally iso-
lated from a human case in Uganda (Meyer and Morgan, 1973)
and shows characteristics consistent with earlier cattle and human
isolates from Zimbabwe (Table 1). Also, the B. abortus strain iso-
lated from a human patient in Kenya almost 40 years ago (Table 1)
was considered “atypical”. B. suis biovar 1 has been clearly iden-
tified but only in cattle in Zimbawe (Table 1), which suggests its
presence in pigs. The only evidence of B. canis is limited to two
strains isolated in South Africa almost ten years ago (Gous et al.,
2005). Bacteriological evidence of B. ovis (a non zoonotic species
restricted to sheep) exists for several SSA countries (Ate et al., 2011;
Cameron et al., 1971; De Wet  and Erasmus, 1984; Van Rensburg
et al., 1958).
As stressed before (Sanogo et al., 2013), there is a clear need for
further bacteriological studies in cattle and small ruminants, partic-
ularly with regards to the human disease, supported by molecular
typing. Despite this, the above-summarized evidence suggests the
existence of a typically SSA B. abortus biovar 3a lineage as well as
other genetic variants not clearly represented elsewhere. The data
also suggest epidemiological situations in which infections of small
ruminants by B. abortus occur in areas where they are in contact
with cattle and B. melitensis is absent (co-infections by two  dif-
ferent brucellae are rather unlikely because of the development of
immunity in an ongoing infection and, in fact, they have never been
convincingly proven). It would therefore be important to study to
what extent such epidemiological situations are common. In other
parts of the world, B. abortus has seldom been isolated from sheep,
almost always from aborted ewes that had been in contact with
infected cattle in B. melitensis-free countries (Allsup, 1969; Shaw,
1976). However, it is not known whether this very limited occur-
rence reflects different patterns of management of cattle and small
ruminants or a host preference rooted in the biology of B. abortus,
or both. Significantly, in one case this Brucella species was found
to persist in sheep in the absence of a cattle reservoir (Luchsinger
and Anderson, 1979) and indirect evidence suggests that B. abortus
infected sheep may  act as reservoirs for cattle brucellosis (Allsup,
1969). Concerning the infection of horses by B. abortus, previousb-Saharan Africa: Current challenges for management, diagnosis
.2015.10.023
evidence shows that it is a spill over disease from cattle and that
horses do not act as a reservoir (Cohen et al., 1992).
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Table 1
Characteristics of the B. abortus and B. melitensis strains isolated in SSA.
Country Species Biovar typing N◦ isolates Host Period Reference
Conventional Moleculara
Gambia B. abortus 3 3a Lineage 3 Cattle Not reported (Bankole et al., 2010)
Guinea  Bissau B. abortus 6-Mar n.d.b 7 Cattle 1976–1982 (Verger and Grayon, 1984)c
Ivory Coast B. abortus 3 3a Lineage 1 Cattle 2009 (Boukary et al., 2013)
Kenya  B. melitensis 1 and 3 n.d. 19 Goats Not reported (Philpott and Auko, 1972)
2  n.d. 1 Sheep
1  and 3 n.d. 11 Human 1969–1972 (Oomen, 1976)
1  1 Cattle Not reported (Muendo et al., 2012)
B.  abortus A¨typical¨ n.d. 1 Human 1969–1972 (Oomen, 1976)
3  3a Lineage 2 Cattle Not reported (Muendo et al., 2012)
Mali  B. abortus 1 n.d. 4 Cattle 1991 (Tounkara et al., 1994)
Natal  B. melitensis 1 n.d. 7 Goat 1994 (Reichel, 1996)g
Niger B. abortus 3 or 3/6 n.d 2 Cattle 1976–1982 (Verger and Grayon, 1984)c
3 3a Lineage 1 2007–2008 (Boukary et al., 2013)
Nigeria  B. abortus 1, 2 n.d 13 Cattle 1974–1976 (Eze, 1978)
1,  3, 4 n.d. 11 Not reported (Bale and Kumi-Diaka, 1981)
3  3a Lineage 30 1976–2012 (Bertu et al., 2015)d
3 3a Lineage 2 Sheep 1976–2012 (Bertu et al., 2015)d
5 1977 (Okoh, 1980)
3  3a Lineage 2 Horses 2004 (Bertu et al., 2015)d
1 n.d 8 Goats Late 1970s (Falade, 1981a,b)
B.  melitensis 1 n.d. 23 Goats Late 1970s
n.d. n.d. 6 Not reported (Bale et al., 2003)
4  Sheep
Rwanda B. abortus 3 or 3/6 n.d 10 Cattle 1982–83 (Verger and Grayon, 1984)c
Senegal B. abortus n.d n.d 6e Cattle 1960-1962 (Chambron, 1965)
n.d  n.d 14 1976 (Doutre et al., 1977)
3  (one 1) n.d 213 1976–1982 (Verger and Grayon, 1984)c
Somalia B. melitensis n.d n.d 1 Human 1975 (Wheat et al., 1995)
Tanzania B. abortus 3 ? (Not 3a) Cattle 2012–2013 (Mathew et al., 2015)
Togo  B. abortus 3 or 3/6 n.d 30 Cattle 1976–1982 (Verger and Grayon, 1984)c
3 or 3/6 3a Lineage 3 2011–2012 (Dean et al., 2014)
Uganda B. abortus 1, 3, 7 (?) ? (Not 3a) 11 Cattle 2011–2012 (Mugizi et al., 2015a,b)
B.  melitensis n.d. n.d 1 2011–2012 Mugizi 2015 (unpublished)
Zimbawe B. abortus 3 n.d ≥4  Human 1921–1930 (Bevan, 1930)f
n.d. 1 1 Cattle Not reported (Ledwaba et al. 2014)
B.  suis n.d. 1 2 Cattle Not reported
B.  melitensis 1 n.d 1 Goat 1987 (Madsen, 1989)
a Molecular typing, where reported, was done according to (Le Fleche et al., 2006) and is simplified here as 3a lineage because of the greater relatedness to the Tulya strain
of  biovar 3 [see (Ocampo-Sosa et al., 2005); however, the analyses show internal diversity [see {(Bertu et al., 2015)]. The study by Ledwaba et al. (2014) was  done by whole
genome  sequencing.
b n.d., Not done.
c This study includes the strains reported by Akapko (Akakpo, 1987) and Akapko and Bornarel (Akakpo and Bornarel, 1987), all of which were sent to the reference
laboratory of M.  Verger at INRA for a definite typing by oxidative metabolic tests.
d This study includes most strains previously reported by Ocholi et al. (Ocholi et al., 2004a,b, 2005) all of which were originally typed as B. abortus biovar 1.
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he One of the strains isolated from cattle in his study showed features partially co
f A strain of this set of isolates was denominated as the “Rodesian abortus” (Stab
g Same strains as those reported by (Emslie and Nel, 2002).
.2. Serological evidence
Serological evidence of brucellosis is abundant throughout SSA.
owever, it is scattered in time and space and, in addition, good
uality data that can be interpreted in strict epidemiological terms
re rather scarce (Ducrotoy et al., 2014; Mangen et al., 2002;
cDermott and Arimi, 2002). Over a decade ago, McDermott and
rimi (McDermott and Arimi, 2002) noted that the figures reported
ad to be interpreted with caution because of uncertainties in test
mplementation and validation. Tables 2 and 3 summarize serolog-
cal surveys accessible in PubMed that meet strict scientific criteria
see Supporting Material) published since 2001 and they show that
he challenges and uncertainties related to the serological tests
emain (see also Section 6.2.1). Despite these diagnostic uncertain-
ies, a number of studies in Africa show that individual brucellosis
eroprevalence correlates with the number of abortions (Akakpo,
987; McDermott and Arimi, 2002; Megersa et al., 2011a; MumaPlease cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
t al., 2012), as expected (see Section 1).
It is a matter of debate whether brucellosis (sero) prevalence is
igher under extensive or intensive breeding conditions (Ducrotoyt with B. melitensis.
 and Jones, 1963) and belongs to biovar 3, possibly 3a.
et al., 2014). Concerning individual seroprevalence, McDermott and
Arimi (McDermott and Arimi, 2002) summarized data prior to 2001
in cattle as varying from 7.5 to 40% for pastoralists in arid and
semiarid areas, 0.3–25.4% for cash/subsistence crops with livestock
in sub-humid areas, 1.5–16.2% for crop-livestock in tropical high-
lands and 2.4–45.0% for crop with small-scale livestock production
in humid areas. The wide range in values indicates that, based on
early evidence, it is not possible to draw general conclusions on the
significance of these production systems on the individual preva-
lence, as already observed by Mangen et al. (Mangen et al., 2002).
This is confirmed by the studies published since 2001 (Table 2) and,
indeed, the lack of a uniform trend conforms to the well-known
variable clinical picture at individual and herd levels summarized in
the Introduction. The same authors also commented that, although
highly variable, the data suggested that individual prevalence was
usually greater in systems in which large numbers of cattle mix
and lowest for small confined herds. Indeed, herd size, movementb-Saharan Africa: Current challenges for management, diagnosis
.2015.10.023
and congregation of animals for access to pastures, water, or mar-
keting figure among the well-known risk factors of brucellosis and
have been identified consistently in previous and more recent stud-
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Table  2
Seroprevalence studies in SSA cattle since 2001a.
Country Population/production system % Seroprevalence (no.) Diagnostic test (antigen) Reference (comments)
Individual Herd
Cameroon Bos Indicus, (n.s.) 3.1 (1377) 15.9 (146) cELISA (VLA)b (Scolamacchia et al., 2010)
Chad  Nomadic pastoral 6.6c (608) n.s. RBT (Sanofi) and iELISA
(CHEKIT)d in series
(Schelling et al., 2003)
Ethiopia Pastoral 15 (68) n.s. RBT (n.s.) (Molla and Delil, 2015)
Pastoral 1.0 (1152) 4.9 (164) RBT (n.s.) and CFT (n.s.) in
series
(Adugna et al., 2013)
Dairy  small holders 1.7 (417) n.s. RBT (n.s.) and iELISA (Prionics)e
in series
(Tschopp et al., 2013)
Urban & peri-urban dairy, commercial,
breeding
1.9 (2334) 10.6 (273) RBT (Lilidale) and CFT (n.s.) in
series
(Asmare et al., 2013a,b) (Herd
prevalence 8.6, 16.9 and 20.0% in urban
and peri-urban dairy, commercial and
breeding farms, respectively)
Pastoral 8 (575) 51.7 (58) RBT (Pourquier) and CFT (VLA)
in series
(Megersa et al., 2012)
Dairy farms 1.5 (1202) n.s. RBT (n.s.) and CFT (n.s.) in
series
(Tesfaye et al., 2011)
Pastoral 10.6 (283) n.s. RBT (n.s.) and CFT (n.s.) in
series
(Megersa et al., 2011a,b)
Mixed  crop-livestock system,
small-holder dairy
4.9 (1238) 16 (176) RBT (Pourquier) (Jergefa et al., 2009)
2.9  (1238) 13.6 (176) CFT (VLA)
Semi-intensive 7.7 (1120) 63.6 (110) RBT (Pouquier) and CFT (n.s.) in
series
(Mekonnen et al., 2010)
Extensive 1.2 (848) 3.3 (210)
Pastoral & mixed crop-livestock 3.86 (985) 22.9 (105) RBT (Pourquier) and CFT (n.s.)
in series
(Ibrahim et al., 2010)
Urban semi-intensive 1.97 (610) 8.2 (122)
Mozambique Wildlife-livestock interface 9.77 (133) n.s. RBT (Onderstepoort) (Tanner et al., 2014)
Niger  Urban 2 (973) n.s. iELISA (n.s.)e (Boukary et al., 2013)
Peri-urban 1.8 (1473) n.s.
Rural pastoral 4.6 (724) n.s.
Nigeria Pastoral, agropastoral, commercial,
zero-grazing
36.6 (4745) 84.9 (271) RBT (VLA) (Mai  et al., 2012) (Prevalence highest
in pastoral system > zero-
grazing >agro-past> commercial).
24  (4745) 77.5 (271) cELISA (VLA)b
South
Africa
Rural 1.45c
(46025)
n.s. RBT (n.s.) and CFT (n.s.) in
series
(Hesterberg et al., 2008)
Togo  Rural 9.4 (596) n.s. RBT (Bio-Rad) (Dean et al., 2013) (Samples positive to
RBT but negative to ELISA were
screened with CFT but unclear if this is
taken into consideration for
seroprevalence interpretation).
5.7  (464) n.s. iELISA (IDEXX)b
Nomadic pastoral 7.3 (596) n.s. RBT (Bio-Rad)
4.5 (464) n.s. iELISA (IDEXX)b
Uganda Urban and peri-urban zero-grazing
/mixed crop livestock/large scale dairy
5.9c (423) 6.5c (177) cELISA (VLA)b (Makita et al., 2011)
Pastoral 34 (497) 100 (9) cELISA (Svanova)b (Magona et al., 2009)
Zero-grazing 3.3 (226) 5.5 (146)
Pastoral 15.8 (5987) 78.6 (106) RBT (Pourquier) (Bernard et al., 2005)
Agro-pastoral 12.8 (4542) 46.4 (209)
Zambia Commercial & small-scale mixed
dairy-beef farms
14.3 (897) n.s. (55) RBT (Onderstepoort) (Chimana et al., 2010)
8.7  (897) n.s. (55) cELISA (Svanova)b
Wildlife-livestock interface 19c (1245) 63c (123) RBT (VLA) and cELISA
(Svanova)b
(Muma et al., 2007a,b)
Zimbabwe Wildlife-livestock interface 9.9 (1158) n.s. RBT (VLA) and cELISA
(Svanova)b in series
(Gomo et al., 2012)
Small-holder dairy farms 5.6c (1440) 25.6c (203) RBT (VLA) and cELISA
(Svanova)b
(Matope et al., 2011)
a Abbreviation used in the Table, cELISA- competitive ELISA; iELISA- indirect ELISA; RBT, rose Bengal test; CFT-, complement fixation test; n.s., not specified; VLA, Veterinary
Laboratory Agency.
b Manufacturer cut-off applied.
d spe
i
1
2
e
nc Prevalence value adjusted according to sampling method +/− test sensitivity an
d Cut-off determined using ROC plot.
e Cut-off not specified.
es in Africa (Akakpo, 1987; Berhe et al., 2007; Kadohira et al.,Please cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
997; Megersa et al., 2011a,b; Mekonnen et al., 2010; Muma  et al.,
007a,b; Sanogo et al., 2012). However, although these factors co-
xist under extensive breeding conditions, namely pastoralism and
omadism, these management systems are not necessarily associ-cificity.
ated with a higher individual prevalence. In two excellent reviews,b-Saharan Africa: Current challenges for management, diagnosis
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Akapko and Bornarel (Akakpo, 1987; Akakpo and Bornarel, 1987)
summarized work carried out in Burkina-Faso, Togo, and Rwanda
showing that individual prevalence was higher in settled than in
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Table 3
Seroprevalence studies in small ruminants in SSA since 2001a.
Country Population/production
system
% Seroprevalence (no.) Diagnostic test (antigen) Reference (comments)
Sheep Goats
IndividualFlock Individual Herd
Chad Nomadic
pastoral
0 (367) NS 0 (374) NS RBT (Sanofi) and iELISA (CHEKIT)b in
series
(Schelling et al., 2003)
Ethiopia Pastoral 3 (77) NS 0 (184) NS RBT (NS) (Molla and Delil, 2015)
Extensive
mixed
crop-livestock
1.4
(490)
NS  5.5 (495) NS mRBT (Lilidale) and CFT (NS) in series (Teklue et al., 2013) (overall flock
prevalence 28.3%)
Sedentary, agro-pastoral and pastoral 1.9 (3315) 11.2
(448)
mRBT (NS) and CFT (NS) in series (Asmare et al., 2013a,b)
Pastoral 1.6 (1248) 13.3
(98)
RBT (Pourquier) and CFT (VLA) in series (Megersa et al., 2012)
Pastoral 1.9 (757) NS RBT (NS) and CFT (NS) in series (Megersa et al., 2011a,b)
Pastoral 4.8
(563)
NS RBT (NS) and CFT (NS) in series (Ashenafi et al., 2007)(seroprevalence
pooled for sheep and goats)
Niger  Urban 3.6
(216)
NS 0.7 (106) NS iELISA (NS)c (Boukary et al., 2013)
Peri-urban 0.6
(320)
NS 0 (150) NS
Rural pastoral 2.1
(650)
NS 0.4 (583) NS
Sudan NS 2.15
(2005)
NS RBT (NS) (Gumaa et al., 2014) (one out of 400
samples mRBT negative found to be
cELISA positive)
3.4
(2005)
NS  mRBT (NS)
Togo  Rural 0 (465) NS 0 (221) NS mRBT (Bio-Rad) and iELISA (IDEXX)d (Dean et al., 2013) (samples positive to
RBT but negative to ELISA were
screened with CFT but unclear if this is
taken into consideration for
seroprevalence interpretation).
Wildlife-
livestock
interface
0  (280) 0 (29) RBT (VLA) and cELISA (Svanova)c (Muma et al., 2006) (pooled sheep and
goat data)
a Abbreviation used in the Table, cELISA: competitive ELISA; iELISA: indirect ELISA; RBT: rose Bengal test; CFT: complement fixation test; NS: not specified, VLA: veterinary
laboratory agency.
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c Cut-off not specified.
d Manufacturer cut-off applied.
ranshumant nomadic herds, and this is also observed in some
ecent studies.
In the course of the European Union funded ICONZ project
http://www.iconzafrica.org), a cross-sectional survey for brucel-
osis was carried out in the Kachia Grazing Reserve (KGR) of Kaduna
Nigeria). These reserves were established in Nigeria in an attempt
o settle nomadic populations to avoid clashes with local farmers.
owever, KGR is actually a dynamic system where only about half
f the population is settled, and even settled households practice
easonal transhumance. Cattle (n, ca. 2000; 40 households) and
mall ruminants (n, ca. 1500) were serologically examined using
he rose Bengal test and, albeit in a limited number of cases, the
resence of B. abortus (biovar 3a) was confirmed by bacteriologi-
al isolation. In cattle, the apparent seroprevalences were ca. 1.0%
nd 20% at individual and herd level respectively and brucellosis
n small ruminants was hardly detected. This picture conforms
o a situation of endemicity and moderate rates of transmission
hat, in addition to the intrinsic dynamics of the disease summa-
ized in the Introduction may  have several causes related to animal
anagement and environmental conditions. Fulani have intuitive
isease-reducing management practices (e.g. rapid disposal of ani-
als that abort, or those with poor fertility or low milk yields,
nd removal of foetuses and placenta from the environment), andPlease cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
he low reproductive rates in KGR should also reduce transmis-
ion (Racloz et al., 2013). In addition, animals on the move in the
unny, dry and hot weather of the Nigerian Savannah (conditions
hat, in contrast to those of temperate climates, drastically reducepathogen viability in the environment [Corbel et al., 2006]) should
be less exposed to severe challenges, as proposed by early Nige-
rian researchers (Esuruoso, 1974) and suggested by others for the
lowlands of Ethiopia (Berhe et al., 2007). Observations in Mozam-
bique, Cameroon, Ivory Coast, Burkina Faso and Niger also suggest
a correlation between climate and rate of infection, the latter being
lower in dry and hot weather (Akakpo, 1987; Akakpo and Bornarel,
1987). Significantly, the same diagnostic methodology used in KGR
found individual apparent seroprevalences of ca. 19% and 13% in
cattle (n, ca. 350) of nearby intensive dairy farms. This exemplifies
how management can drastically alter the picture of brucellosis
in the same area and the high risk of brucellosis emergence in
intensively managed herds in SSA and elsewhere (Akakpo, 1987;
Ducrotoy et al., 2014; McDermott and Arimi, 2002). B. abortus bio-
var 3a was isolated from cattle in both KGR and the intensive farms,
which illustrates the potential for extensively managed herds to act
as reservoirs even though in these herds the disease is manifested
only in a low number of individuals.
Diametric opposite epidemiological pictures to those seen in
KGR and the close intensive farms are not uncommon. Concurrent
low individual but high herd seroprevalences have been reported
before (Akakpo, 1987; Akakpo and Bornarel, 1987; McDermott
and Arimi, 2002) and since 2001 they have been documented inb-Saharan Africa: Current challenges for management, diagnosis
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Cameroon, Ethiopia and Zimbawe in different production systems
(Table 2). Both early and more recent studies have also found high
seroprevalences at both individual and herd level in extensively
or semi-extensively managed herds (McDermott and Arimi, 2002).
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Table  4
Seroprevalence studies in humans in SSA since 2010a.
Country Population Sampling Diagnostic test (antigen/cut-off) %
Prevalence
(no.)
Reference
Uganda Abattoir workers NS MAT  & STAT in series (≥1:60) 10 (232) (Nabukenya et al., 2013;
Schelling et al., 2003)
Togo Fulani and non-Fulani
villagers
Random selection villages
(GPS ref) and households
(along transect)
RBT (Bio-Rad) 0.44 (683) (Dean et al., 2013; Megersa
et al., 2012)
iELISA IgG (manufacturer [Serion]) 0.73 (683)
iELISA IgM ((manufacturer [Serion]) 0.15 (683)
Nigeria Abattoir workers Stratified random sampling RBT (NS) & IgG/IgM iELISA (NS) in
parallel
24.1 (224) (Aworh et al., 2013; Megersa
et al., 2011b)
Tanzania Febrile patients Prospective cohort study MAT  (NVSL) 3.5 (455) (Ashenafi et al., 2007; Bouley
et al., 2012)
Ethiopia Febrile patients Prospective cohort study Rapid slide agglutination (Human
GmbH, Wiesbaden))
2.6 (653) (Animut et al., 2009)
Tanzania Traditional &
small-scale farming
community
Cross-sectional survey RBT (VLA) 5.5 (199) (Swai and Schoonman, 2008)
Chad  Nomadic pastoralist
community
Cross-sectional survey RBT (Sanofi) & iELISA (CHEKIT/ROC
plot) in series
3.9 (860) (Schelling et al., 2003)
Namibia Abattoir workers Random sampling SAT (Linear/≥1:80) & IgG/IgM ELISA
(Panbio) in parallel
2.2 (137) (Magwedere et al., 2012)
Ethiopia Farm workers, abattoir
workers, veterinarians
Cross-sectional survey RBT (NS) 10.4 (336) (Kassahun et al., 2006)
2-ME (NS) 4.8 (336)
a
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iAbbreviations used in the Table: NS: not specificied; MAT: micro-agglutination
AT:  serum agglutination test; 2-ME: 2-mercaptoethanol test.
everal of the reports in Table 2 studies illustrate the relatively
igh herd seroprevalences (6.5–10.2%) that can be found in urban
r peri-urban dairy or mixed dairy farms (Table 2), as observed by
thers (Mugizi et al., 2015a,b; Muma  et al., 2007a,b; Yohannes et al.,
013). Indeed, these are of great concern as regards to public health.
nsurprisingly, the existence of a number of variables related to
limate and geographical parameters, management, human habits,
tc., across SSA make it difficult to predict the impact of the disease,
mphasizing the necessity to carry out specific investigations.
As compared to cattle, there is limited information on brucel-
osis in small ruminants in SSA. It is considered that brucellosis in
hese livestock species is caused mostly by B. melitensis but, as indi-
ated above, bacteriological studies are very limited (Table 1) and
ifferent epidemiological scenarios are plausible. The pattern of
ndividual/collective prevalence discussed above for cattle is likely
o apply to small ruminants, as suggested by the scarce literature
vailable (Ducrotoy et al., 2014; McDermott and Arimi, 2002). The
ew recent studies generally indicate a low individual prevalence
hat could reflect a common existence of chronically infected flocks
nd herds (Table 3). However, flock or herd prevalences have been
eldom if ever reported, and these are necessary for a complete pic-
ure and an assessment of the problems that the disease may  pose
f breeding conditions and epidemiological circumstances change.
Information on pig brucellosis is rather scarce and often of dif-
cult interpretation because of the problems associated with the
pecificity of serological tests in these animals (Ducrotoy et al.,
014; McDermott and Arimi, 2002). Yet, its presence in at least
imbabwe seems likely (see above). Similarly, camels present in
he arid and semi-arid areas of Sahel and East Africa often react in
erological tests for brucellosis, suggesting usually low individual
eroprevalences (Adugna et al., 2013; Bekele et al., 2013; Ducrotoy
t al., 2014; Gwida et al., 2012; McDermott and Arimi, 2002;
egersa et al., 2011a, 2012, 2006; Schelling et al., 2003; SpraguePlease cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
t al., 2012). When reported, herd seroprevalence has been found
o be relatively high [15% (Megersa et al., 2012); 25.6% (Matope
t al., 2011) and 24% (Bekele et al., 2013)]. However, the tests used
n these surveys have not been validated in these animals (SpragueTAT: serum tube agglutination test; RBT: Rose Bengal Test; iELISA: indirect ELISA;
et al., 2012). Similarly, the scarce evidence on B. canis is based on
tests of unknown specificity (Gous et al., 2005; Muhairwa et al.,
2012), a critical problem because of the problems associated with
agglutination tests (B. canis antigens auto-agglutinate [Carmichael
and Shin, 1996]) and the cross reactivity between smooth and rough
brucellae in immunoenzymatic methods (Nielsen et al., 2005).
3.3. Control and vaccination
Official data on the existence of control measures and degree
of implementation (i.e. figures for outbreaks, number of ani-
mals involved, slaughtered and vaccinated, etc.) in SSA can be
found on the OIE Handistatus webpage (http://web.oie.int/hs2/
) for the 1996–2004 period, and in the WAHID (http://www.
oie.int/wahis 2/public/wahid.php/Wahidhome/Home) from 2004
onwards. However, when they are contrasted with the literature
and the estimated numbers and distribution of susceptible ani-
mals (Fig. 1), it is clear that these official records have very limited
or no value. McDermott and Arimi (McDermott and Arimi, 2002)
covered the information available up to 2002 and concluded that
vaccination was  rarely conducted outside of southern Africa and
that, if done, it was mostly on an ad hoc basis, rather than as part
of a systematic campaign. For this region, the disease was reported
to be notifiable in several countries, and surveillance, movement
control, and stamping out or vaccinations were implemented in
Botswana, Namibia, Lesotho and South Africa. In Zimbabwe con-
trol programs were targeted to specific cattle production systems.
A test-and slaughter program was partially implemented in goats
in KwaZulu-Natal, which apparently managed to reduce prevalence
but not to eradicate the infection. Problems reported in the imple-
mentation of this policy were not different from those observed
elsewhere (i.e. time and financial constraints and stockowner dis-
illusionments with the compensations) (Emslie and Nel, 2002).b-Saharan Africa: Current challenges for management, diagnosis
.2015.10.023
Where implemented, vaccination of cattle was  carried out using
B. abortus S19 (McDermott and Arimi, 2002) and, since 2002, B.
abortus RB51 (Davey, 2014; Ekron, 2008). More recently, vaccine
RB51 has been introduced in other SSA countries, like Mozambique
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nd Zambia (Muma  et al., 2012). South Africa is possibly the only
ountry that has implemented a sustained effort based on a classical
ontrol and eradication strategy. However, bovine brucellosis has
ot been eradicated and it appears that the situation is worsening
ith more than 250 outbreaks/year reported since 2003 (Davey,
014).
. Brucellosis in wildlife
The earliest reports of serological evidence of exposure to Bru-
ella spp. in free-ranging wild animals in Southern Africa are
ttributed to Rollinson (cited in Guilbride et al., 1962) and Guilbride
nd co-workers (Guilbride et al., 1962) in Tanzania and Uganda,
espectively. Later, similar serological surveys in other countries
uch as Kenya (Waghela and Karstad, 1986), South Africa (De Vos
nd Van Niekerk, 1969), Tanzania (Sachs and Staak, 1966), Zam-
ia (Bell et al., 1977) and Zimbabwe (Condy and Vickers, 1972)
orroborated these reports. It is noteworthy that these and more
ecent studies consistently reported antibodies to Brucella spp.
n wild animals like the African buffalo (Syncerus caffer), impala
Aepyceros melampus),  blue wildebeeste (Connochaetus taurinus)
nd zebra (Equus burchelli), but were found to be erratic in other
pecies (Alexander et al., 2012; Condy and Vickers, 1972; De Vos
nd Van Niekerk, 1969; Herr and Marshall, 1981; Waghela and
arstad, 1986). There are indications that the odds of seropositive
eactors tend to increase in gregarious wild animal species such
s the buffaloes, eland (Taurotragus oryx), impalas and wildebeest
Condy and Vickers, 1972; Madsen and Anderson, 1995) and are less
f an issue in solitary animals like the white (Ceratotherium simum)
nd black (Diceros bicornis) rhinoceros. In fact brucellosis has not
een reported in either the black or white rhinoceros (AQUIS, 1999;
otsi et al., 2013), and their susceptibility to Brucella spp. and/or
bility to seroconvert needs to be explored further.
Although the Brucella spp. involved and wild animal host range
ave not been established, brucellosis has been confirmed by the
solation of B. abortus biovar 1 in buffaloes, eland (Tragelaphus
ryx) and waterbuck (Kobus ellipsipymnus)  (Condy and Vickers,
969; Gradwell et al., 1977; Thornton, 1976) and B. melitensis from
mpalas (Schiemann and Staak, 1971). Similar to livestock, clinical
igns of brucellosis in wildlife have been related to carpal hygroma,
rchitis and abortions (Gradwell et al., 1977; Kaliner and Staak,
973; Thornton, 1976). The observed inconsistency of reported
bortions (Condy and Vickers, 1976) may  be related to inadequate
isease surveillance in wildlife.
The epidemiological significance of brucellosis in relation to the
isk of transmission to livestock and humans has been debated
xtensively in the literature (Bishop and Bosman, 1994; Motsi
t al., 2013). It is widely believed that Brucella spp. originate
rom livestock and spill over into wildlife, where in some species,
hey appear to perpetuate in the absence of contact with cattle.
lthough the general argument is that the risk of transmission
o domestic animals is low due to infrequent contact (Madsen
nd Anderson, 1995), the creation of the large landscape mosaics
nder the transfrontier conservation area (TFCA) initiatives in SSA
as allowed sharing of the same ecological systems by wildlife,
omestic animals and humans and may  thus promote inter-species
ransmission of Brucella spp. Sharing the same ecological space with
omestic animals has been shown to be an important risk factor for
rucellosis in wildlife (Bell et al., 1977; Muma  et al., 2010; Sachs
nd Staak, 1966) while in the absence of contact with cattle, for
nstance, the black lechwe (Kobus leche smithemani) in BangweuluPlease cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
lains in Zambia have remained free of brucellosis for many years
Muma  et al., 2011). Therefore, the interface created in the TFCAs
ay  bring about an intractable situation where brucellosis is intro-
uced from domestic animals into wildlife where control is hardly PRESS
ica xxx (2015) xxx–xxx
practicable. The presence of Brucella spp. in wildlife in addition to
domestic animals compounds the public health risk of brucellosis,
especially for resource-poor communities living at the periphery
of the TFCAs since their livelihood is largely dependent on animals
and animal products. Therefore, in the quest for One Health in the
TFCAs and surrounding areas, it would be important to break the
transmission of Brucella spp. by re-enforcing control with the view
of eradicating brucellosis in domestic animals in these areas (see
below).
5. Human brucellosis in SSA
Similar to the disease in ruminants, there is fragmented sero-
logical evidence of human brucellosis across the different SSA
countries (Ducrotoy et al., 2014; Gomo et al., 2012; McDermott
and Arimi, 2002; Pappas et al., 2006; Rubach et al., 2013) but few
assess disease frequency using probability sampling methods. Dean
et al. (Dean et al., 2012) reviewed the literature published between
1990 and June 2010 and found only one article providing valid
data on brucellosis frequency in Africa (Chad). Table 4 covers more
recent but similarly scarce data that show the presence of anti-
bodies, particularly in the classical risk groups (concerns about the
use of non-validated diagnostic methods also apply here). Regret-
tably, there is an almost total absence of bacteriological studies (see
above) that are strictly necessary to establish whether the relative
risks of contact with B. abortus and B. melitensis observed elsewhere
applies to SSA. Indeed, reports on infections by either B. abortus or
B. melitensis based on antibody titres against the respective anti-
gens such as those provided in “febrile antigen” kits (Chipwaza
et al., 2015; Ducrotoy et al., 2014) are meaningless as it was estab-
lished over 70 years ago that identification of infecting species is
not possible by serology (Huddleson, 1943; Spink, 1956).
Suspicion of underreporting is accentuated by the fact that a
significant proportion of malaria-suspected cases actually show
a brucellosis-positive serology (McDermott and Arimi, 2002).
Although in general the number of human cases should follow
the incidence in animals and be higher in the classical risk groups
(Ducrotoy et al., 2014; McDermott and Arimi, 2002), the situa-
tion can fluctuate depending on the proximity of contact between
humans and livestock, the existence of different Brucella spp. and
biovars, the alimentary and cultural habits of the population and
possibly other factors. In a large study carried out in Niger, Ivory
Coast and Burkina Faso (Gidel et al., 1976) it was found that, while
the animal disease was more prevalent in the South, the rate of
human infections was  higher in the Northern Sahelian areas, and
authors attributed this to the alimentary habits of the local popu-
lace and to the closer animal-human contacts due to environmental
conditions (see also (Roux, 1979). For KGR (see above), no seropos-
itives were detected in over 1100 humans tested using the rose
bengal test (RBT), serum agglutination and Coombs tests, includ-
ing butchers. Serologically negative human cases are exceedingly
infrequent (Díaz et al., 2011) and, therefore, it seems that human
brucellosis in KGR is remarkably rare. This is striking because Fulani
in the KGR engage in risky practices such as drinking of unpas-
teurized milk. Several hypotheses can be proposed to account for
this result, including (1) reduced persistence of the pathogen in
the environment (see above), (2) shedding of brucellae in milk in
numbers lower than those observed in cattle reared under optimal
conditions, and (3) the cattle management habits of Fulani (3.1).
A comparatively lower virulence of biovar 3a for humans cannotb-Saharan Africa: Current challenges for management, diagnosis
.2015.10.023
be ruled out, as this is known to occur in some B. suis biovars, but
this hypothesis is not fully consistent with some bacteriological
evidence (see above), and the identification of human disease in
outbreaks and risk groups in Nigeria (Ducrotoy et al., 2014).
 ING ModelA
a Trop
6
6
i
p
c
i
t
i
w
a
t
1
m
m
a
r
b
a
b
a
c
n
t
b
c
e
a
a
c
i
d
2
w
t
T
r
(
a
D
n
w
r
t
(
a
e
o
s
6
6
t
1
o
t
i
f
t
i
Three brucellosis vaccines are presently marketed worldwide:
B. abortus S19 and B. abortus RB51 against brucellosis in cattle and B.
melitensis Rev 1 against brucellosis in small ruminants.1 It is impor-ARTICLECTROP-3767; No. of Pages 15
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. Tools for the SSA context
.1. Human brucellosis
Under most circumstances, the existence of human brucellosis
s the best indicator of the animal disease, and emphasis has to be
laced on its diagnosis. This is based on the existence of compatible
linical symptoms and, as these overlap with those of some other
nfectious diseases, laboratory tests. An important consideration
hat emphasizes the need for laboratory tests is that the overall clin-
cal picture of the human disease is often different in urban areas
ith easier access to medical facilities, where cases may  be detected
t an earlier stage, than in rural areas where chronic forms are likely
o develop, or depending on the infecting Brucella species (Ariza,
999; Young, 1989). Furthermore, inappropriate therapy caused by
isdiagnosis may  hide the symptoms and thus lead to the develop-
ent of permanent sequelae without awareness of their brucellosis
etiology (Roux, 1979). It is obvious that all these circumstances are
elevant in many SSA settings.
Bacteriological culture (usually blood culture) is of great value
ut it requires both skill and adequate facilities that are seldom
vailable in SSA. On the other hand, simple serological tests com-
ined with an evaluation of each case by a clinician should yield
 correct diagnosis in the overwhelming majority of cases. In bru-
ellosis, agglutinating antibodies are progressively substituted by
on-agglutinating antibodies and, therefore, standard agglutina-
ion tests need to be complemented with the Coomb’s test for
rucellosis (Ariza, 1999; Díaz et al., 2011). Immunoenzymatic tests
an detect both types of antibodies but they have not been prop-
rly validated for human brucellosis. Simpler and very effective
re RBT and the Brucellacapt, two tests that detect both non-
gglutinating and agglutinating antibodies because of the acidic
onditions used (Díaz et al., 2011). RBT has shown its usefulness
n resource-poor settings particularly when adapted to test serum
ilutions rather than plain serum (Díaz et al., 2011; Mantur et al.,
014), and its implementation is highly recommended. It is note-
orthy that the first recommendations in this regard came from
he early work of African physicians (Oomen and Waghela, 1974).
he relatively recently developed lateral flow immunochromatog-
aphy test (Smits et al., 2003) is also a simple and promising test
Díaz et al., 2011), even though the commercial kit presently avail-
ble shows serious standardization problems (Conde-Álvarez, R.
íaz and I. Moriyón unpublished observations).
Therapy is based on expensive combined antibiotic regimes that
eed to be modified when complications develop, or in pregnant
omen and children, and has to be sustained for weeks to minimize
elapses (Ariza et al., 2007). However, in many resource-poor set-
ings compliance is difficult and, moreover, the classical treatment
aminoglycosides plus doxycycline) conveys the risk of hepatitis
nd HIV transmission through syringes. Solera (Solera, 2010) has
mphasized that prolonged doxycycline monotherapy (cheap and
ral) should be useful in most cases, and this alternative deserves
pecific clinical trials in SSA.
.2. Animal brucellosis
.2.1. Diagnostics
While there is a limited choice of media and protocols for
he bacteriological diagnosis of animal brucellosis (Alton et al.,
988; de Miguel et al., 2011), there are a bewildering number
f serological tests. Those most often used in blood sera include
he RBT (or its equivalent, the card test), serum agglutinationPlease cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
n tube (SAT; not recommended by OIE for brucellosis testing
or the purpose of international trade), the complement fixation
est (CFT), the indirect (iELISA) and competitive (cELISA) enzyme-
mmunoassays, the fluorescence polarization assay (FPA) and the PRESS
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lateral flow immunochromatography test. These tests can be used
for sero-epidemiological surveys but also to monitor the disease
once control (and vaccination) is implemented. In the latter case,
the RBT screening followed by the assessment of the RBT-positive
sera by CFT has been widely used in countries where eradication
was achieved and where the relatively sophisticated CFT can be
implemented, often in an automatized format.
Although RBT is generally used as a screening test for its simplic-
ity and CFT as a “confirmatory” test, this diagnostic strategy has led
to the extended belief that RBT shows low specificity in all circum-
stances and is only a “presumptive” test (Ducrotoy et al., 2014).
Following this misconception, an increasing tendency in recent
literature is the reliance on technically appealing and expensive
quantitative tests, such as iELISA, cELISA or FPA, to the detriment of
the simpler, cheaper and more robust RBT. However, whereas it is
well established that iELISA and cELISA do not have better sensitiv-
ity and specificity than RBT in the absence of vaccination (Greiner
et al., 2009), even under the conditions in SSA (Nizeyimana et al.,
2013), they have to be validated in the target populations (OIE,
2013a). Moreover, cut-offs recommended by the makers in Europe,
the USA or Canada are unlikely to be adequate in SSA. The main
reason for this is the existence of biological factors affecting the
serological background that are not equal in different populations
(Greiner and Gardner, 2000; Thrusfield, 2013). In brucellosis, such
factors include management, male/female ratios and age distribu-
tion, animal breed, differences in reproductive periods, repeated
exposure to the pathogen in endemic areas, vaccination (by either
smooth or rough vaccines; see below) and variable degrees of expo-
sure to cross-reacting bacteria related to hygiene, to autochthonous
microbiota or other causes. The trend to use these more fashion-
able tests seems to uncritically follow the necessity of developed
economies to use tests that can be automated for the survey of very
large numbers of animals in brucellosis-free areas, and overlooks
that diagnosis of brucellosis in successful control and eradication
programs was achieved efficiently using simpler tests (Alton, 1981;
Moreno, 2014). Yet, the experience of the authors of this review
and others (Maichomo et al., 1998) is that even simple tests such
as RBT require proper training and standardization, like any other
brucellosis test.
For antibodies in milk, the literature reveals an indiscriminate
use of the milk ring test (Ducrotoy et al., 2014) overlooking that
this test can only be used in cattle and not in small ruminants or
camels, and that it is affected by the quality of milk (Alton et al.,
1988). A milk antibody test could be useful in some circumstances
in SSA but, although it is well known that several ELISA formats
can be adapted to detect immunoglobulins in milk, to the best of
our knowledge none has been validated for diagnostic sensitiv-
ity/specificity in any SSA setting. Similarly, a particularly difficult
and largely unsolved problem is an accurate serological diagnosis of
brucellosis in wildlife species. Indeed, the diagnostic specificity and
sensitivity of serological tests need to be established for each ani-
mal  species using appropriate diagnostic criteria as references, and
suitable studies investigating the performance of serological tests
in African wildlife are rare or non-existent. Regrettably, the same
problem affects the interpretation of serological results in camels
(Sprague et al., 2012).
6.2.2. Vaccines and complementary measuresb-Saharan Africa: Current challenges for management, diagnosis
.2015.10.023
1 Here, we  only consider the vaccines accepted by OIE. Among the long series of
proposed brucellosis vaccines, only vaccine B. suis 2 has been used extensively and
only in China. This vaccine was claimed to protect all animal species, even orally (Xin,
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ant to stress that they are “host vaccines” and not vaccines against
 given Brucella species. Accordingly, S19 (or RB51) should be used
nly in cattle and Rev 1 only in small ruminants no matter whether
he animals are exposed to B. abortus or B. melitensis,  as the bacte-
iological evidence suggests may  happen in different SSA contexts
see above). In all cases, emphasis must be placed on the use of
accines produced under strict quality control to prevent genetic
rifts and dissociation. Internationally accepted biological and bac-
eriological protocols for quality control exist for S19 and Rev 1 but
urprisingly not for RB51 (OIE, 2013a). To the best of our knowledge,
ith the exception of South Africa, no SSA country has the nec-
ssary technology, and vaccines produced locally, particularly in
iquid form, are of no guarantee. These are freeze-dried live vaccines
nd, therefore, the cold chain should be maintained to guarantee
iability and constant bacterial numbers of the final lyophilized
roduct. The reader is directed to a recent review where the advan-
ages, potential problems and conditions of use of the available
accines are discussed in depth (Blasco et al., 2015), and here we
nly summarize their main characteristics: protection, interference
n serological tests and abortifacient effect. When these are consid-
red together, it is clear that S19 is the only cattle vaccine that can
e recommended for SSA, and that conjunctival vaccination is the
oute of choice for vaccine administration.
Both controlled studies and field observations with appropriate
ontrol groups demonstrate that S19 is superior to RB51 (Moriyón
t al., 2004). Contrary to strain 19 that provides long-life useful
mmunity (Nicoletti, 1990) the “protective” lapse span of RB51
accine has not been investigated but RB51 revaccination, even
f pregnant animals, has been used without success in attempts
o bolster immunity (Herrera et al., 2008; Herrera-Lopez et al.,
010; Leal-Hernandez et al., 2005; Luna-Martinez and Mejia-Teran,
002; Moriyón et al., 2004). Moreover, no controlled experiments
ave addressed the advantages of these expensive revaccination
trategies. Finally, it has been proven that S19 protects cattle
gainst B. melitensis infection, but this has not been proven for the
B51 vaccine. Concerning the serological interference, it is usually
rgued that while S19 vaccination interferes in serological diagno-
is, RB51 does not. However, RB51 vaccination generates antibodies
eacting in iELISA, cELISA (Nielsen et al., 2005) and FPA (Blasco
nd Moriyón, unpublished results). Moreover, animals vaccinated
ith RB51 develop anti-S-LPS antibodies when exposed to virulent
trains (Moriyón et al., 2004), as expected, which shows that they
ay  become positive in S-LPS tests under field conditions creating
onfusion on the infection or vaccinated status. An additional con-
ideration is that serological interference in standard tests is only
mportant when animals are tagged and a test-and-slaughter strat-
gy can be implemented, which is not the case in the overwhelming
ajority of situations in SSA. Indeed, if serological interference
ecomes relevant (when moving from control to eradication) the
roblem can be minimized by applying S19 by the conjunctival
rather than the subcutaneous) route during calfhood (Nicoletti
t al., 1978; Plommet and Fensterbank, 1976; Jiménez de Bagüés
t al., 1991).
Both S19 and RB51 can induce abortions in pregnant cattle, but
his is reduced to less than 1% when S19 is administered by conjunc-
ival route (see below). Despite early claims (Schurig et al., 2002),Please cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
 high proportion of animals vaccinated with RB51 in the second
alf of the gestation abort (Mainar-Jaime et al., 2008; OIE, 2013a).
ubcutaneous vaccination of males with S19 is not recommended
986). These claims attracted some attention in the 70’s, and FAO commissioned sev-
ral  studies to independent reference laboratories. These experiments performed
oth in laboratory models and under controlled conditions in natural hosts (Blasco
t  al., 1993; Bosseray and Plommet, 1990; Verger et al., 1995) demonstrated the
oor efficacy of this vaccine and its use was thus unsupported by FAO. PRESS
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because of the risk of development of genital infections. It would be
worth investigating whether conjunctival S19 vaccination is safe in
bulls as dispersion of the vaccine through the body is very limited
by this route (Blasco et al., 2015).
Rev 1 has been essential in the eradication of B. melitensis infec-
tion in sheep and goats in some European Mediterranean countries
and the properties and drawbacks of this vaccine are well-known
(Blasco, 1997). As for S19, conjunctival vaccination is the procedure
of choice. Using this route the post-vaccinal serological response is
minimized and Rev 1 is safe in rams and billy goats. However, no
matter the route, this vaccine is highly abortifacient and is excreted
in milk when applied to pregnant sheep and goats. As indicated
above, Rev 1 is markedly virulent for humans and, moreover, it is
resistant to streptomycin (a drug that combined with oxytetracy-
cline is of choice for treating human brucellosis [see below]). These
are important drawbacks when “mass vaccination” is the only pos-
sible strategy (see below).
When using brucellosis vaccines, it is critical to understand that
there is a biological limit to their effectiveness. For B. abortus,  it has
been estimated that up to 1014 bacteria are released during an abor-
tion (Corner, 1983), which altogether represents about 109 and 105
times the estimated infectious dose 70 of unvaccinated and S19 vac-
cinated heifers (Manthei, 1959). Thus, it is not surprising that even
the immunity provided by the best vaccines can be overcome upon
continuous and direct exposure to recent abortions and abortion
fluids. Revaccination does not improve immunity and, indeed, this
would be unpractical or unfeasible under most conditions. There-
fore, it is clear that for any vaccination program to be successful it
is essential to create conditions that minimize exposure. Of utmost
importance is the separation of animals during calving and lamb-
ing/kidding and in the next weeks that follow, plus proper disposal
of aborted foetuses and placentas, the removal of replacements
born to infected mothers, and other well-known general hygiene
measures (Corbel et al., 2006). Education campaigns to improve
awareness of brucellosis and other zoonoses with emphasis on the
mechanisms of transmission are of paramount importance.
6.3. Control and eradication strategies
Long experience shows that interventions to control and erad-
icate brucellosis need to be based on engagement with livestock
keepers, education and complementary measures and, where fea-
sible and necessary, vaccination (Corbel et al., 2006). When the
resources and capacity for control are limited, interventions could
be tailored to the impact of the disease in terms of magnitude of
burden in potential animal and human hosts. Evaluating the impact
of brucellosis, however, is difficult because of the dual burden of
disease in humans and animals, the role of several animal host
species in transmission or as reservoirs, the diverse epidemiologi-
cal picture at herd or flock level, and the variability of the clinical
picture in humans. Broadly speaking, where human disease is an
occasional occurrence and the individual prevalence remains low in
animals, brucellosis possibly ranks as a low priority disease whose
effects can be minimised by education, basic hygiene measures
in animal management and milk pasteurization. However, it has
to be kept in mind that these herds and flocks represent a reser-
voir that can affect other production systems and develop into a
more serious situation if the conditions change. Thus, vaccination
should be considered even in these low prevalence situations. On
the other hand, if human brucellosis is significant, the problem
has a completely different dimension that, in addition, will most
often include an important incidence in animals causing signif-b-Saharan Africa: Current challenges for management, diagnosis
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icant economic losses by reducing meat and milk outputs. Even
though each case requires specific studies in SSA, intensive produc-
tion systems are more threatened by brucellosis and small holders
or backyard livestock keepers in zero grazing systems are particu-
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Fig. 2. Decision making tree for controlling/eradicating brucellosis.
Once the presence of brucellosis has been established in humans and/or animals,
the  critical points are whether the veterinary services can effectively implement
vaccination, animals can be individually identified by tagging, a census is available,
breeders are actively engaged in the program and the necessary funds available.
When these requisites are not met, mass vaccination (B. abortus S19 in cattle and
B.  melitensis Rev 1 in small ruminants) is the only option, no matter the preva-
lence (for details see text). When collective prevalence is high, no matter whether
those requisites are met, mass vaccination is also the only realistic option. Usually,
after  implementation of mass vaccination and even though the collective prevalence
remains high, the individual prevalence decreases and then a program based on
the combination of vaccination of young replacements with serological testing and
culling of seropositives can be considered after careful re-evaluation of the means
available. A final step under very favourable conditions would be the removal of
vaccination. Yet, experience shows that the most common mistake in brucellosis
control/eradication is the premature removal of S19 and Rev 1 (or the substitu-
tion of the former by less effective vaccines) a situation that, but for international
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ment generation every year. This would require individual tagging,rade requisites, is unnecessary and of no benefit to most breeders in poor-resource
reas.
arly vulnerable (Mangen et al., 2002). In these cases, vaccination
s immediately necessary. In addition, attention should be given to
he communities in the periphery of the TFCAs because of the clear
isk of introduction of brucellosis into wildlife. If this happened,
hen control in wild species would be exceedingly difficult (if not
mpossible) with subsequent health implications to the new hosts
nd the establishment of a permanent reservoir, as the cases of the
merican bison and elk illustrates (Treanor, 2013).
Fig. 2 summarizes the strategies proposed by several authors
or the control and eradication of the disease (Benkirane, 2006;
lasco and Molina-Flores, 2011). Prevalence at herd or flock level
collective prevalence), level of veterinary coverage and organi-
ation, appropriate control of animal movements and economic
esources are the main requisites necessary to decide on the strat-
gy once the presence of brucellosis (including the human disease)
as been established. When the proficiency of veterinary servicesPlease cite this article in press as: Ducrotoy, M.,  et al., Brucellosis in Su
and control. Acta Trop. (2015), http://dx.doi.org/10.1016/j.actatropica
s not adequate (no matter the prevalence), and when collective
revalence is high, mass vaccination of all animals (with the excep-
ion of bovine males) of all species is the only strategy to control PRESS
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the disease. All the above requisites are essential, however, when
moving towards eradication programs based on the vaccination of
young replacements (3–4 months old) and test and slaughter in
adult animals or when the eventual banning of vaccination and
implementation of a test-and-slaughter only program is foreseen
(Fig. 2).
In  addition to economic, political and geographical difficulties,
animal health services provided by the public sector are insuffi-
cient in SSA and, in general, the gap has not been filled by the
private sector (McDermott and Arimi, 2002). A strategy based on
vaccination of young replacements (3–4 months old) and test-and-
slaughter in adult animals is unrealistic under extensive pastoralist
production in SSA and elsewhere (Blasco et al., 2015; Blasco and
Molina-Flores, 2011). Test and slaughter is not feasible and, because
owners keep replacements throughout the year in these systems,
several field visits would be required to attain full vaccine coverage,
which increases costs and is seldom feasible. This problem is com-
pounded by the difficulties of including small farms with very few
animals and localizing all animals in nomadic pastoralist systems.
Accordingly, control by repeated (see below) mass vaccination is
the only realistic strategy for most SSA areas. Indeed, this does not
exclude actions targeted to control brucellosis in specific produc-
tion systems or farms or to the more vulnerable settled herds and
flocks. For these systems, once prevalence is reduced, vaccination
could be restricted to young replacements to solve the problems
intrinsic to mass vaccination that are commented upon below.
Mass vaccination (i.e. vaccinating all animals—but for males in
the case of S19—with a reduced dose dispensed by conjunctival
instillation regardless of age and pregnancy) was  proposed in the
early seventies for resource poor or remote areas on the basis that,
since testing is not routine and test-and-slaughter not applicable
in such areas, the serological interference is irrelevant. Moreover,
census and identification (ear tagging is not necessarily permanent,
it is expensive and may  promote myiasis and ear infections in tropi-
cal and hot climates) of vaccinated animals are not possible in those
areas. However, the undesirable side effects of the vaccines on preg-
nant and lactating animals should be explained to livestock keepers.
Although conjunctival S19 vaccination of lactating cows results in
0.1–1% of mammary infections and milk excretion and in 0.1–1%
abortions in pregnant cows, experience shows that adult vaccina-
tion is the most practical and economic way to control the disease in
cattle (Blasco et al., 2015). Moreover, it has been shown that when
mass vaccination is implemented, removal of seropositive animals
does not result in a more rapid decrease of prevalence (Enright and
Hugh-Jones, 1984), which greatly facilitates implementation of this
strategy in difficult contexts.
Regrettably, the safety problems of Rev 1 in pregnant sheep and
goats are far greater than those of S19 in cattle and the rates of
abortion and milk excretion can be very high. This together with
the subsequent risks of human infections by Rev 1 make the vac-
cination of pregnant sheep and goats unacceptable (Blasco, 1997).
Conjunctival vaccination during the late lambing or kidding, lac-
tation and pre-mating periods are indeed the safest times. Thus,
it may  be possible to find relatively safe “time windows” in areas
where parturitions are concentrated across a few weeks because of
the seasonal availability of pastures, or where the demand of ani-
mals peaks in a short period because of cultural, religious or other
reasons. Use of this vaccine in contexts where there is no seasonal
breeding, however, is problematic.
To be effective, vaccination has to be maintained over time. Once
a first mass vaccination with S19 or Rev 1 has been applied, the
ideal procedure would be to vaccinate only the next young replace-b-Saharan Africa: Current challenges for management, diagnosis
.2015.10.023
a measure that, as indicated above, is unrealistic in many situations
in SSA. An alternative is to consider the rates of annual replacement
and the epidemiological risks according to age, i.e. sexually mature,
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regnant animals are more liable to become infected and suscep-
ibility may  increase with the length of gestation (Enright, 1990).
or example, if the annual replacement were about 20%, as in many
xtensive management systems, one year after the first mass vac-
ination only 1/5 of the livestock would be young replacements.
ince these replacements are sexually immature they are excluded
rom the period of maximal risk of infection and spreading and it is
cceptable not to vaccinate them. However, in the next year, almost
alf of the population would be unprotected and a significant pro-
ortion would be sexually mature, so that mass vaccination is again
n order. This two-year mass vaccination strategy has been applied
uccessfully with few side effects in areas where those safe “time
indows” exist (Blasco, 1997). For Rev 1, it is important to stress
hat failure to adhere to such windows may  have dramatic conse-
uences in terms of abortions and milk excretion. There is a clear
eed for a safer small ruminant brucellosis vaccine for areas where
hese conditions do not apply.
Monitoring of vaccination programs is essential. A representa-
ive sample of animals should be tested with RBT at 15–21 days after
accination and between 70 and 90% of these vaccinated animals
hould test positive. To assess the efficacy of the control strategy,
he evolution of brucellosis in the exposed human population in
he vaccinated area should be followed through screening of people
ith the RBT.
. Concluding remarks
Presently, brucellosis in SSA poses a series of challenges that
ncompass not only the necessary assessment of the prevalence of
he disease in humans and animals, including wildlife, and the influ-
nce of the various local epidemiological characteristics but also
everal important methodological gaps that concern the tools to
iagnose and combat the disease. As outlined above, although sim-
le and affordable serological tests are available for the diagnosis
f human brucellosis, there is a need for simpler and more afford-
ble antimicrobial treatments. Concerning brucellosis in domestic
ivestock, perhaps the greatest need concerns the development of a
. melitensis vaccine that could circumvent the abortifacient effects
f Rev 1. These represent a serious drawback for the implemen-
ation of mass vaccination in small ruminants, the only realistic
trategy in many areas of SSA and elsewhere. The need to inves-
igate the safety of S19 in bulls when administered conjunctively
as been stressed above. It is also important to fill the gap in sero-
ogical diagnostic tests for camel brucellosis, and to investigate
he performance of serological tests in wildlife. Brucellosis in pigs
emains unexplored and very little is known about B. canis and B.
vis. Finally, although out of the scope of the present review, it is
mportant to stress that control strategies based on any existing
nd future tools need delivery methods optimized for the various
ocio-economic contexts in SSA countries (McDermott and Arimi,
002).
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